-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Neutral on Teladoc Health, Lowers Price Target to $7

Benzinga·03/13/2026 16:26:48
Listen to the news
JP Morgan analyst Lisa Gill maintains Teladoc Health (NYSE:TDOC) with a Neutral and lowers the price target from $9 to $7.